1.Results of 6 month short course chemotherapy for pulmonary tubercul-osis with 2SHRZ/4HR.
Hyong Ju LEE ; Chul Hong MIN ; Sun Woo LEE ; In Won PARK ; Byoung Whui CHOI ; Sung Ho HUE
Tuberculosis and Respiratory Diseases 1991;38(2):93-98
No abstract available.
Drug Therapy*
2.A case of simultaneous presentation of symptomatic PCM and MDS unrelated to prior chemotherapy.
Hyerim KIM ; Sang Hyuk PARK ; Eun Yup LEE ; Moo Kon SONG
Blood Research 2015;50(3):179-181
No abstract available.
Drug Therapy*
3.Adverse factors of hepatic dysfunction during chemotherapy for childhood malignancy.
Dong Hoon KOH ; Hyung Jong LIM ; Young Kwon CHOI ; Hoon KOOK ; Tae Joo HWANG
Journal of the Korean Cancer Association 1993;25(3):417-422
No abstract available.
Drug Therapy*
4.Clinical evaluation of a totally implantable venous access system for long-term anticancer chemotherapy.
Tejune CHUNG ; Won Sang CHUNG ; Young Hak KIM
Journal of the Korean Cancer Association 1991;23(2):424-428
No abstract available.
Drug Therapy*
5.Complications of early postoperative intraperitoneal chemotherapy.
Journal of the Korean Cancer Association 1991;23(4):821-827
No abstract available.
Drug Therapy*
6.Chemotherapy.
Journal of the Korean Gastric Cancer Association 2002;2(3):133-135
No abstract available.
Drug Therapy*
7.Recent New Trends of Anticancer Drug Therapy.
Journal of the Korean Geriatrics Society 2004;8(3):128-136
No abstract available.
Drug Therapy*
8.Recent Trend of Drug Therapy in allergic Diseases-Anti-allergic Drugs.
Journal of the Korean Medical Association 1997;40(3):330-336
No abstract available.
Drug Therapy*
9.The Principles of Antiepileptic Drug Therapy.
Journal of the Korean Pediatric Society 2003;46(Suppl 2):S277-S285
No abstract available.
Drug Therapy*
10.Oral Pharmacotherapy for Erectile Dysfuction.
Journal of the Korean Medical Association 1999;42(2):124-131
No abstract available.
Drug Therapy*